J. Box

1.5k total citations · 1 hit paper
10 papers, 1.1k citations indexed

About

J. Box is a scholar working on Genetics, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, J. Box has authored 10 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Rheumatology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in J. Box's work include Chronic Lymphocytic Leukemia Research (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Lymphoma Diagnosis and Treatment (3 papers). J. Box is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Lymphoma Diagnosis and Treatment (3 papers). J. Box collaborates with scholars based in United States, Mexico and Belgium. J. Box's co-authors include Yvonne Sherrer, Richard Aranda, Michael E. Luggen, Mark C. Genovese, Isaac Nuamah, C. Birbara, Joel Kremer, Michael Schiff, Kannan Natarajan and Tracy Li and has published in prestigious journals such as New England Journal of Medicine, Annals of the Rheumatic Diseases and The Journal of Rheumatology.

In The Last Decade

J. Box

10 papers receiving 1.1k citations

Hit Papers

Abatacept for Rheumatoid Arthritis Refractory to Tumor Ne... 2005 2026 2012 2019 2005 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Box United States 7 763 367 356 217 204 10 1.1k
Yvonne Sherrer United States 7 921 1.2× 441 1.2× 391 1.1× 218 1.0× 234 1.1× 11 1.3k
Joel Kremer United States 7 1.1k 1.4× 464 1.3× 534 1.5× 306 1.4× 190 0.9× 12 1.5k
B. Combe France 13 638 0.8× 301 0.8× 247 0.7× 151 0.7× 87 0.4× 22 959
Mitchell B. Lowenstein United States 10 732 1.0× 343 0.9× 284 0.8× 201 0.9× 161 0.8× 19 1.1k
K Steinsson Iceland 19 628 0.8× 401 1.1× 150 0.4× 82 0.4× 180 0.9× 35 928
Kouichi Amano Japan 15 575 0.8× 216 0.6× 165 0.5× 143 0.7× 96 0.5× 35 758
Edit Drescher United States 13 922 1.2× 486 1.3× 463 1.3× 211 1.0× 67 0.3× 35 1.3k
G. Cavet United States 11 605 0.8× 217 0.6× 171 0.5× 100 0.5× 121 0.6× 17 780
K. N. Verpoort Netherlands 13 1.5k 2.0× 378 1.0× 205 0.6× 180 0.8× 760 3.7× 17 1.8k
Andrew R. Baldassare United States 12 402 0.5× 295 0.8× 151 0.4× 187 0.9× 220 1.1× 19 829

Countries citing papers authored by J. Box

Since Specialization
Citations

This map shows the geographic impact of J. Box's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Box with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Box more than expected).

Fields of papers citing papers by J. Box

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Box. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Box. The network helps show where J. Box may publish in the future.

Co-authorship network of co-authors of J. Box

This figure shows the co-authorship network connecting the top 25 collaborators of J. Box. A scholar is included among the top collaborators of J. Box based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Box. J. Box is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Genovese, Mark C., César Pacheco‐Tena, Eduardo Mysler, et al.. (2018). Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial. The Journal of Rheumatology. 45(8). 1085–1092. 21 indexed citations
4.
Keystone, Edward, Joel M. Kremer, Anthony S. Russell, et al.. (2012). Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE study. Annals of the Rheumatic Diseases. 71(6). 857–861. 43 indexed citations
5.
Genovese, M. C., G. Léon, Eduardo Mysler, et al.. (2012). FRI0193 SC vs IV abatacept in RA: post-hoc efficacy analysis of long-term acquire (SC) data with aim (IV) data. Annals of the Rheumatic Diseases. 71. 378–378. 2 indexed citations
6.
Genovese, Mark C., Jean‐Claude Becker, Michael Schiff, et al.. (2005). Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition. New England Journal of Medicine. 353(11). 1114–1123. 920 indexed citations breakdown →
7.
Kiebzak, Gary M., et al.. (2002). Prospective Analysis of Body Composition and SF36 Profiles in Professional Dancers over a 7-Month Season: Is There a Correlation to Injury?. Journal of Dance Medicine & Science. 6(2). 54–61. 8 indexed citations
8.
Kiebzak, Gary M., et al.. (1999). Decreased Ulnar Bending Stiffness in Osteoporotic Caucasian Women. Journal of Clinical Densitometry. 2(2). 143–152. 12 indexed citations
9.
Willkens, Robert F., Murray B. Urowitz, Donald M. Stablein, et al.. (1992). Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. Arthritis & Rheumatism. 35(8). 849–856. 94 indexed citations
10.
Pisko, Edward J., Robert A. Turner, Michael D. Parker, et al.. (1979). Cardiopulmonary Manifestations of Progressive Systemic Sclerosis. Arthritis & Rheumatism. 22(5). 518–523. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026